2539 Middle Country Rd, Suite 4 · Centereach, NY 11720
📞 (631) 737-6434 office@eastendneuropsych.com Leave a Review Patient Portal Staff Login
East End Neuropsych East End Neuropsych
📞 (631) 737-6434 · After-hours voicemail reaches on-call provider
Navigation
About the Practice › Meet Our Team › Conditions Treated ›
Programs
IV Ketamine Infusions › IV Ketamine: Learn More ›
Patient Resources
Fee Schedule › Education & Resources › New Patient Registration › Contact & Directions › 🔐 Patient Portal ›
Legal & Policies
Privacy Policy (HIPAA) › Terms of Service › SMS Policy & Opt-Out ›
Appearance
Staff Login
A moon and sleeping Zs beside a brain outline with the pons marked as the region that controls muscle paralysis during REM sleep.

Sleep and the Aging Brain: Why REM Sleep Behavior Disorder Matters

·

A 68-year-old man's wife complains that he's been "fighting in his sleep" for the past few years. Sometimes he punches the air, kicks the mattress, or shouts incoherently. Last week, he gave her a black eye while dreaming of fending off an intruder. Her friends laugh it off — "all men act out in their sleep." Her primary care doctor suggests he cut back on caffeine.

What this man almost certainly has is REM Sleep Behavior Disorder (RBD). And what many clinicians don't realize is that idiopathic RBD is one of the strongest predictors of future Parkinson's disease, Lewy body dementia, or multiple system atrophy — with conversion rates exceeding 80% within 10–15 years.

What Is RBD?

During normal REM (dream) sleep, the brain paralyzes the body through active motor inhibition from the pontine brainstem. This is why we dream of running but don't actually run. In RBD, this paralysis fails. The dream content is physically acted out.

Key features:

  • Vigorous, often violent dream-enactment behavior
  • Dream content typically involves being chased, attacked, or defending oneself
  • Occurs during the second half of the night (when REM is more frequent)
  • Patient may recall the dream upon waking
  • Unlike sleepwalking, eyes are typically closed and patient is difficult to arouse
  • Behaviors can injure the patient or bed partner

The Synucleinopathy Connection

This is where neurology meets psychiatry and geriatrics in a profound way. RBD is caused by degeneration of brainstem nuclei that normally produce REM atonia — specifically, the sublaterodorsal nucleus in the pons. These neurons are among the first affected by abnormal alpha-synuclein deposition.

Alpha-synuclein is the pathological hallmark of three related diseases (the "synucleinopathies"):

  • Parkinson's Disease (PD)
  • Dementia with Lewy Bodies (DLB)
  • Multiple System Atrophy (MSA)

Current research suggests alpha-synuclein pathology begins in the olfactory bulb and lower brainstem (Braak stages 1–2) before ascending to the substantia nigra (stages 3–4) and eventually to cortex (stages 5–6). RBD marks the transition from stage 2 to stage 3 — which is why it can precede motor or cognitive symptoms by a decade or more.

How Common Is Conversion?

Longitudinal studies tell a sobering story:

  • At 5 years: ~33% of idiopathic RBD patients develop a synucleinopathy
  • At 10 years: ~60%
  • At 14 years: ~80%
  • At 20 years: >90%

Among those who convert, roughly equal numbers develop PD vs DLB. A smaller minority develop MSA.

The Psychiatric Cross-References

Differential diagnosis

RBD can be confused with several conditions that psychiatrists see frequently:

  • Nocturnal panic attacks — abrupt awakening with autonomic symptoms, but without motor activity during sleep
  • PTSD nightmares — also involve violent dream content but occur in NREM as well as REM, and patients typically wake fully oriented
  • Nocturnal seizures — stereotyped movements, often involves tongue biting or incontinence
  • Non-REM parasomnias — sleepwalking, night terrors — occur in first third of night, eyes open, no dream recall
  • Medication-induced dream enactment — SSRIs, SNRIs, TCAs, and bupropion can all cause RBD-like symptoms; stopping the medication resolves it

Medications that can cause or worsen RBD

Before diagnosing idiopathic RBD, review:

  • SSRIs and SNRIs (most common culprits)
  • Tricyclic antidepressants
  • MAOIs
  • Bisoprolol, metoprolol
  • Bupropion
  • Alcohol withdrawal

If RBD emerges after starting a medication, consider that it may be revealing an underlying vulnerability rather than being simply drug-induced.

The Diagnostic Workup

  • Clinical history — detailed bed partner interview is essential
  • Polysomnography (sleep study) — required for diagnosis, demonstrates REM sleep without atonia
  • Neurological exam — subtle parkinsonian signs, postural instability, cognitive screening
  • Olfactory testing — hyposmia often coexists, reinforcing synucleinopathy risk
  • Autonomic testing — orthostatic vitals, constipation history

Management

Symptomatic treatment

  • Melatonin — 3–12 mg at bedtime, first-line, good safety profile
  • Clonazepam — effective but cautious use in older adults (falls, cognitive effects)
  • Safety modifications — padded bed rails, moving lamps and sharp objects, separate beds temporarily

Counseling the patient

This is delicate territory. Patients deserve to know that RBD is a marker for future neurological disease, but the information must be delivered with appropriate context: conversion takes years to decades, not everyone converts, and lifestyle factors (exercise, sleep, diet) may modify risk. Some patients want full information for life planning; others do better with less. Tailor accordingly.

Opportunity for neuroprotection research

RBD patients are ideal candidates for clinical trials of disease-modifying therapies for synucleinopathies — they have the biology without yet having the full clinical syndrome. If a treatment that prevents conversion from RBD to PD is ever developed, these patients will be the first beneficiaries.

The Geriatric Frame

RBD is primarily a condition of older adults, with peak onset in the 50s to 70s. In our geriatric practice, we screen for dream-enactment behavior in all patients with cognitive concerns, mood disorders, or new-onset parkinsonism. A positive history fundamentally changes our diagnostic trajectory — it points us toward synucleinopathy rather than Alzheimer's-type dementia, which has major implications for prognosis and treatment (e.g., avoiding anticholinergics and dopamine-blocking antipsychotics).

The Takeaway

Dream-enactment behavior in an older adult is not a quirk — it's a window into the earliest stages of neurodegeneration. Recognizing it early doesn't cure the underlying process, but it allows us to anticipate, plan, protect, and potentially intervene if disease-modifying therapies become available.

At East End Neuropsych, we integrate sleep history into every geriatric neuropsychiatric evaluation. If a family member has concerning sleep behaviors, contact our office for a comprehensive evaluation.

This article is for educational purposes and does not constitute medical advice. Always consult your healthcare provider for individual diagnosis and treatment.

← Back to all articles